CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $236,518 | +16.5% | 4,213 | +35.3% | 0.09% | -16.5% |
| Q3 2022 | $203,000 | -34.9% | 3,113 | -24.3% | 0.10% | -2.8% |
| Q4 2021 | $312,000 | -10.1% | 4,113 | +32.5% | 0.11% | -22.1% |
| Q3 2021 | $347,000 | -30.0% | 3,103 | +1.3% | 0.14% | -27.7% |
| Q2 2021 | $496,000 | +33.0% | 3,063 | 0.0% | 0.19% | +24.5% |
| Q1 2021 | $373,000 | -18.7% | 3,063 | +2.1% | 0.15% | -22.2% |
| Q4 2020 | $459,000 | +92.9% | 3,000 | +5.3% | 0.19% | +59.0% |
| Q3 2020 | $238,000 | – | 2,850 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |